Study: Abdominoplasty Patients Find Pain Relief with Xaracoll Implant
Among abdominoplasty patients receiving Xaracoll, a reduction in pain intensity and opioid use was observed through 24 hours post-surgery.
Among abdominoplasty patients receiving Xaracoll, a reduction in pain intensity and opioid use was observed through 24 hours post-surgery.
Establishment Labs Holdings Inc, a global medical technology company specializing in women’s health, announces the first U.S. breast augmentations using Motiva Implants.